Skip to content
healthcare.dev
Get a free key

OXBRYTA

NDC 72786-111, Voxelotor, tablet, for suspension, from Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc..

Product NDC
72786-111
Status
Listed
Labeler
Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216157
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72786-111 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VOXELOTOR300 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Hemoglobin S Polymerization Inhibitor [EPC]; Hemoglobin S Polymerization Inhibitors [MoA]

Package NDCNDC-11Package
72786-111-027278601110260 TABLET, FOR SUSPENSION in 1 BOTTLE, PLASTIC (72786-111-02)
72786-111-037278601110390 TABLET, FOR SUSPENSION in 1 BOTTLE, PLASTIC (72786-111-03)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3c557fac-29ec-483f-b691-8a935d4decc3

Use it

Look up 72786-111 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72786-111 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72786-111. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.